| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/20/2013 | CN101912408B Application of alginate sulfuric ester in preparing drugs for preventing and treating diabetes and vascular diseases |
| 03/20/2013 | CN101899051B 1-azaxanthone-3-formamide compounds as well as preparation method and antitumor application thereof |
| 03/20/2013 | CN101888839B Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for the treatment of ophthalmic conditions |
| 03/20/2013 | CN101820883B Uses of A3AR agonist in preparing medicine for inducing hepatocyte proliferation |
| 03/20/2013 | CN101778830B Particulates of a crth2 antagonist |
| 03/20/2013 | CN101773654B Herbal paste for treatment of femoral head necrosis and manufacturing process thereof |
| 03/20/2013 | CN101772499B Tricyclic N-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 03/20/2013 | CN101712659B Compound with platelet aggregation resisting activity and preparation method thereof |
| 03/20/2013 | CN101687819B Novel preparation for external use |
| 03/20/2013 | CN101677978B Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 03/20/2013 | CN101674807B Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
| 03/20/2013 | CN101669936B Drug combination containing pratensein and application thereof in drugs |
| 03/20/2013 | CN101663326B Process methods for fucoidan purification from seaweed extracts |
| 03/20/2013 | CN101654664B Fermentation production method and application of high-yield exopolysaccharide strain and amylase thereof |
| 03/20/2013 | CN101653422B Risperidone slow-release microsphere, preparation method and application thereof |
| 03/20/2013 | CN101648865B Polyphenol acrylic acid derivative and application thereof in medicaments |
| 03/20/2013 | CN101624360B Substituted organic sulfur compound and application thereof |
| 03/20/2013 | CN101618071B Compound radix salviae miltiorrhizae film slow-release tablet and preparation method thereof |
| 03/20/2013 | CN101588803B Intermediate duration neuromuscular blocking agents and antagonists thereof |
| 03/20/2013 | CN101583357B Use of MTOR antagonist and angiogenesis inhibitor for preparing medicine for treating cancer |
| 03/20/2013 | CN101573338B Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives |
| 03/20/2013 | CN101563068B Sustained-release composition and method for producing the same |
| 03/20/2013 | CN101544572B Ambroxol derivative and method for preparing same |
| 03/20/2013 | CN101543546B Antioxidative substance and composition and use thereof |
| 03/20/2013 | CN101541821B Crystalline forms of 1,6-bis [3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyl-oxy)-phenyl] hexane |
| 03/20/2013 | CN101538305B Method for preparing composite with antineoplastic activity by panoxadiol |
| 03/20/2013 | CN101530589B Chinese medicinal preparation for treating cancers |
| 03/20/2013 | CN101508692B Anthranilamides, process for the production thereof, and pest controllers containing the same |
| 03/20/2013 | CN101486714B Novel oxazine compound and use for preventing platelet aggregation |
| 03/20/2013 | CN101485665B Novel medical use of cucurbitacin |
| 03/20/2013 | CN101478956B Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 03/20/2013 | CN101475596B Platinum complexes of quercetin and derivatives thereof, as well as preparation and use thereof |
| 03/20/2013 | CN101474186B 2,3,4,7,8-polysubstituted naphthyridine [4,3-d] pyridine derivates with anti-tumor activity |
| 03/20/2013 | CN101466709B 1,5 and 3,6- substituted indole compounds having NOS inhibitory activity |
| 03/20/2013 | CN101460505B Thiazolyl-dihydroquinazolines |
| 03/20/2013 | CN101439017B Method for preparing polymer aqueous solution formulation of taxane anti-tumor medicament |
| 03/20/2013 | CN101429164B Levorotation benzhydryl piperazidine derivant and preparing method thereof |
| 03/20/2013 | CN101429107B Lignanoid compounds, producing method, identification method and uses thereof |
| 03/20/2013 | CN101391986B Fluorine triazole ethers derivates and salt with antimicrobial activity, preparation method and uses thereof |
| 03/20/2013 | CN101390831B Docetaxel medical composition for injection and preparation method thereof |
| 03/20/2013 | CN101384266B Fixed-dose association of phytate and zinc |
| 03/20/2013 | CN101371825B Oral sticking tablets using fluticasone propionate as active component |
| 03/20/2013 | CN101370792B Bi-aryl meta-pyrimidine inhibitors of kinases |
| 03/20/2013 | CN101365702B Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 03/20/2013 | CN101342259B Method for extracting alkaloid valid parts from hooked uncaria leaf, with hook stem branch or full grass and uses thereof |
| 03/20/2013 | CN101277683B Retard formulation for pralnacasan |
| 03/20/2013 | CN101277681B Oral solid pharmaceutical formulation of the tribulin inhibitor indibulin |
| 03/20/2013 | CN101243043B Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| 03/20/2013 | CN101242850B Composition, function and use of xanthoceras sorbifolia extract and compound isolated from same, method for preparing same |
| 03/20/2013 | CN101237771B Multidrug resistant anticancer anthracyclines |
| 03/19/2013 | US8399694 Process for producing highly purified orange roughy oil |
| 03/19/2013 | US8399683 IAP inhibitors |
| 03/19/2013 | US8399682 Substituted (pyrazolylcarbonyl)imidazolidinones and their use |
| 03/19/2013 | US8399681 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 03/19/2013 | US8399676 Piperidine derivatives |
| 03/19/2013 | US8399667 4-anilino quinazoline derivatives as antiproliferative agents |
| 03/19/2013 | US8399664 Coloring matter, ink, ink for ink jet, ink jet recording method, color toner, and color filter |
| 03/19/2013 | US8399663 Salt of 1,3,5-triazine-2,4,6-triamine derivative |
| 03/19/2013 | US8399660 Process for the synthesis of triazoles |
| 03/19/2013 | US8399659 Compounds and methods for inhibiting mitotic progression |
| 03/19/2013 | US8399657 Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
| 03/19/2013 | US8399655 Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1′-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof |
| 03/19/2013 | US8399522 3.2.1-bicyclo-octane compounds |
| 03/19/2013 | US8399521 Methods of treating skin with aromatic skin-active ingredients |
| 03/19/2013 | US8399520 Selective estrogen receptor modulator |
| 03/19/2013 | US8399519 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 03/19/2013 | US8399518 Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome |
| 03/19/2013 | US8399517 Calcilytic compounds |
| 03/19/2013 | US8399515 Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| 03/19/2013 | US8399514 Treatment for multiple sclerosis |
| 03/19/2013 | US8399513 Levodopa prodrug mesylate hydrate |
| 03/19/2013 | US8399512 Biocompatible biodegradable fumagillin analog conjugates |
| 03/19/2013 | US8399511 Two types of crystalline of pinocembrin, their preparation and their use for manufacture of pharmaceutical compositions |
| 03/19/2013 | US8399510 Method of activating NK cells |
| 03/19/2013 | US8399509 Glucopyranoside derivatives |
| 03/19/2013 | US8399508 Olopatadine formulations for topical nasal administration |
| 03/19/2013 | US8399507 Antidiabetic tricyclic compounds |
| 03/19/2013 | US8399505 Sulfonylpyrroles |
| 03/19/2013 | US8399504 Carbamate and urea inhibitors of 11Beta-hydroxysteroid dehydrogenase 1 |
| 03/19/2013 | US8399503 Spirocyclic azaindole derivatives |
| 03/19/2013 | US8399502 Analogs of indole-3-carbinol and their use as agents against infection |
| 03/19/2013 | US8399501 Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof |
| 03/19/2013 | US8399500 Method of synthesizing ergothioneine and analogs |
| 03/19/2013 | US8399499 3- to 7-membered 1,3-diaza-4-OXO-heterocyclic derivatives capable of releasing active aldehydes or ketones |
| 03/19/2013 | US8399497 Thiazole derivatives and use thereof |
| 03/19/2013 | US8399496 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| 03/19/2013 | US8399495 Talarazole metabolites |
| 03/19/2013 | US8399494 2,5-disubstituted phenyl carboxamide orexin receptor antagonists |
| 03/19/2013 | US8399493 Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors |
| 03/19/2013 | US8399492 Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 03/19/2013 | US8399491 Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof |
| 03/19/2013 | US8399490 Insecticides |
| 03/19/2013 | US8399489 Antibacterial piperdine derivatives |
| 03/19/2013 | US8399488 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/19/2013 | US8399487 Pyrazole compounds and uses thereof |
| 03/19/2013 | US8399486 Benzenesulfonyl compounds and the use thereof |
| 03/19/2013 | US8399485 Acyl bipiperidinyl compounds useful as GPR 119 agonists |
| 03/19/2013 | US8399484 Combination therapy for treating HCV infection |
| 03/19/2013 | US8399483 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 03/19/2013 | US8399482 6-substituted isoquinolines and isoquinolinones |